<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR59">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hawman</surname>
    <given-names>DW</given-names>
   </name>
   <name>
    <surname>Haddock</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Meade-White</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Williamson</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Hanley</surname>
    <given-names>PW</given-names>
   </name>
   <name>
    <surname>Rosenke</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Komeno</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Furuta</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Gowen</surname>
    <given-names>BB</given-names>
   </name>
   <name>
    <surname>Feldmann</surname>
    <given-names>H</given-names>
   </name>
  </person-group>
  <article-title>Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice</article-title>
  <source>Antivir Res</source>
  <year>2018</year>
  <volume>157</volume>
  <fpage>18</fpage>
  <lpage>26</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.06.013</pub-id>
  <?supplied-pmid 29936152?>
  <pub-id pub-id-type="pmid">29936152</pub-id>
 </element-citation>
</ref>
